STAT

JUNE 26, 2024

In a related move, the Advisory Committee on Immunization Practices opted not to make a recommendation yet on use of GSK’s Arexvy vaccine in adults 50 to 59, saying the committee didn’t have enough data with which to make such a recommendation. Read the rest…

Vaccines 289

Vaccines Immunity Immunization 289

pharmaphorum

JUNE 20, 2023

Lilly bets $2.4bn on Dice’s immune disease platform Phil.Taylor Tue, 20/06/2023 - 15:51 Bookmark this

Immunity 98

Immunity Immunization 98

Pharma Times

JULY 10, 2025

The results, now published in Vaccines , show that the combination was well-tolerated with no serious adverse events, and generated strong immune responses. Robust NP-specific humoral and cell-mediated immune responses were observed in all participants given OVX836, whether alone or with Fluarix Tetra.

Vaccines 82

Vaccines Immunity Immunization 82

PharmaVoice

JULY 9, 2025

The company’s myvac platform creates individualized immunotherapies that stimulate and “educate” a patient’s immune system to destroy cancer tumors. We use AI to select the targets most likely to induce a strong immune response and incorporate these neoantigens into our viral vector.”

Vaccines 179

Vaccines Immunization Immunity Drug Development 179

PharmaVoice

JULY 8, 2025

You just want to slash it, rip it out or attack it like an enemy target,” said Benjamin Zeskind, co-founder, CEO and president of Immuneering Corporation. To overcome that hurdle, Immuneering is testing an approach that slows cancer down rather than rushing to destroy it.

Immunization 130

Immunization Immunity Chemotherapy Packaging 130

Safe Biologics

NOVEMBER 12, 2023

ASBM to Present at World Drug Safety Congress Americas 2023 On October 19th, ASBM Advisory Board Chair Philip Schneider will present at the World Drug Safety Congress Americas 2023 in Boston, Massachusetts. Register for the 2023 National Policy & Advocacy Summit on Biologics here. Read the new FDA’ Guidance here.

Biosimilars 130

Biosimilars Drug Pricing Packaging Labelling 130

pharmaphorum

NOVEMBER 4, 2021

While still preliminary, the experience with the two patients back up Talaris’ hope that giving a one-shot dose of FCR001 the day after an organ transplant could stimulate immune tolerance in the recipient, and avoid the side effects of current drug treatments such as infections, heart disease, and some forms of cancer.

Immunity 98

Immunity Immunization 98

European Pharmaceutical Review

SEPTEMBER 7, 2023

Current limitations of CAR-T therapies could potentially be overcome through new advances in the production of T-cell progenitors, suggests Dr Olivier Negre, Chief Scientific Officer of Smart Immune. The post Bioprocessing & Bioproduction In-Depth Focus 2023 appeared first on European Pharmaceutical Review.

Immunity 98

Immunity Immunization 98

Express Pharma

DECEMBER 9, 2024

15,000 crores and a production tenure from FY 2022- 2023 to FY 2027-28, provides financial incentives to 55 selected applicants for manufacturing of identified products under three categories for six years. The scheme provides financial incentives for the manufacturing of notified products. are manufactured.

Immunization 102

Immunization Immunity 102

Express Pharma

NOVEMBER 21, 2024

Additionally, it is approved in the EU for gMG and in Japan for gMG and primary immune thrombocytopenia (ITP) under brand names Vyvgart and Vyvdura. per cent from 56,009 in 2023 to 56,163 in 2027. The NRDL inclusion secured for gMG lowers the barrier for adoption in CIDP by facilitating reimbursement despite the drug’s high cost.

Immunization 95

Immunization Immunity 95

Express Pharma

DECEMBER 23, 2024

million cases in 2023 to 42.42 Yixuan Zhang, MSc, Epidemiologist at GlobalData, comments, The pathogenesis of AD is unclear and most likely stems from the interaction of a combination of genetic susceptibility, environmental and lifestyle risk factors, and dysfunctional cell-mediated immunity. per cent from around 42.02

Immunization 105

Immunization Immunity 105

ALiEM - Pharm Pearls

OCTOBER 11, 2024

Immune thrombocytopenia (ITP) is an acquired autoimmune disorder caused by autoantibodies against platelet antigens. Case Discussion Take-Home Points Immune thrombocytopenia is an acquired isolated thrombocytopenia that can be a primary disorder or secondary to viral illness, autoimmune syndrome, or immunodeficiency disease.

Immunity 152

Immunity Immunization 152

PharmaTech

JUNE 10, 2025

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. ACIP plays a foundational role in shaping immunization policy in the US. Kennedy Jr.

Vaccines 85

Vaccines Insurance Coverage and Processing Dosage Drug Development 85

STAT

OCTOBER 24, 2024

So far this year, 95 new shortages were reported, a drop from 156 in 2023, although 50% of active shortages have persisted for two or more years. Among the basic and life-saving medicines for which shortages continue to be problematic are Rho(D) immune globulin, pain and sedation medications, and ADHD pills.

Immunization 241

Immunization Immunity Drug Pricing Drug Development 241

pharmaphorum

MAY 27, 2021

If all goes well, CTP-543 could be ready for filing in early 2023, but even so it looks set to reach the AA market well behind Eli Lilly, which reported positive phase 3 results with its JAK 1/2 inhibitor Olumiant (baricitinib) earlier this year. In severe cases it can lead to loss of all head and body hair.

Immunization 105

Immunization Immunity 105

The Thyroid Pharmacist

DECEMBER 16, 2022

I am excited to share that I finished my fourth book (also known as my first book as a mommy) in April of 2022, and it will be released in April 2023! We are hoping to feel more settled in 2023. This is a great option for those looking to support immune health, hormone balance, and metabolic health.

Immunization 95

Immunization Immunity Dosage 95

ALiEM - Pharm Pearls

OCTOBER 21, 2024

A 5-year-old generally healthy fully immunized boy presented to the ED with worsening left ear redness, swelling, and tenderness that his family noticed the day before presentation. His family had also recently noticed an abrasion over that ear. Eur Arch Otorhinolaryngol. 2019 Aug;276(8):2199-2203. doi: 10.1007/s00405-019-05463-z.

Medical Schools 169

Medical Schools Immunization Immunity 169

LifeProNow

MARCH 29, 2023

Roginolisib is a first-in-class, non-ATP-competitive, allosteric modulator of PI3Kd which prevents tumor proliferation and breaks immune tolerance in patients with solid and hematological tumors. Further details on clinical responses will be released at a future international clinical conference in 2023.

Immunity 130

Immunity Immunization Communication 130

PharmaVoice

JULY 8, 2025

Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Is biopharma dealmaking getting hot again?

Packaging 130

Packaging Immunization Immunity 130

PharmaShots

MARCH 24, 2023

PTC Therapeutics’ Upstaza (eladocagene exuparvovec) Receives NICE Recommendation for the Treatment of AADC Deficiency Date: Mar 24, 2023 | Tags: PTC Therapeutics, Upstaza, eladocagene exuparvovec, AADC Deficiency, Regulatory, NICE Onconova Therapeutics Entered into a Research Collaboration with Pangea Biomed to Identify Biomarkers for Cancer (..)

Diabetes 64

Diabetes Immunization Immunity Biosimilars 64

Drug Patent Watch

DECEMBER 9, 2024

Additionally, the immunogenicity of biosimilars, which is the ability of the drug to trigger an immune response, can be highly variable and impact the safety and efficacy of the drug. 2023, June 13). link] Kurki, P., 2021, November 2). Interchangeability of Biosimilars: Overcoming the Final Hurdles. link] Algorics. link] Source

Biosimilars 93

Biosimilars Immunization Immunity 93

European Pharmaceutical Review

JUNE 27, 2023

AC Immune SA has received Fast Track designation from the US Food and Drug Administration (FDA) for its anti-amyloid beta (Abeta) active immunotherapy vaccine candidate for Alzheimer’s disease. The anti-Abeta therapy “specifically targets the most toxic forms of Abeta” according to Dr Andrea Pfeifer, CEO of AC Immune SA.

Vaccines 105

Vaccines Immunity Immunization 105

pharmaphorum

JANUARY 27, 2023

Affimed is using bispecific antibodies to activate the innate immune system of cancer patients to create longer-lasting and more effective results. Hoess describes the company’s clinical programmes, including an ADC for Hodgkin’s lymphoma and a novel cell therapy approach. The post JP Morgan 2023 – Adi Hoess appeared first on.

Immunity 59

Immunity Immunization 59

LifeProNow

MARCH 13, 2023

March 13, 2023 : “Sanofi and Provention Bio, Inc., based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), have entered into an agreement under which Sanofi has agreed to acquire Provention Bio, Inc., for $25.00 for $25.00

Diabetes 130

Diabetes Immunization Immunity 130

Pharmacy Times

SEPTEMBER 13, 2023

The CDC emphasized the need for protein-based vaccine options in endorsing a vote by the Advisory Committee on Immunization Practices for the universal recommendation of the 2023-2024 monovalent, XBB containing COVID-19 vaccines.

Vaccines 55

Vaccines Immunity Immunization 55

Pharmacy Times

SEPTEMBER 25, 2023

For community pharmacists, cooler temperatures, school buses on the roads and Friday night football are not just signs of a changing season – they are indicators that patients will soon be seeking vaccinations for the 2023-2024 respiratory illness season.

Vaccines 59

Vaccines Immunization Immunity 59

European Pharmaceutical Review

MARCH 26, 2024

Moderna’s next-generation COVID-19 vaccine mRNA-1283 demonstrated a higher immune response against SARS-CoV-2, interim results from the company’s Phase III trial show. Further details In October 2023, Moderna shared that the regulatory approval for the combination mRNA-1083 vaccine for adults 50 years and older was targeted for next year.

Vaccines 110

Vaccines Immunization Immunity 110

PharmaShots

APRIL 7, 2023

TG Therapeutics Receives EMA’s CHMP Positive Opinion of Briumvi (ublituximab-xiiy) for the Treatment of Relapsing Forms of Multiple Sclerosis Date: Apr 3, 2023 | Tags: TG Therapeutics, Briumvi, Ublituximab-xiiy, Multiple Sclerosis, Regulatory, EMA, CHMP BMS Receives EMA’s CHMP Positive Opinion of Breyanzi (lisocabtagene maraleucel) for (..)

Biosimilars 53

Biosimilars Immunization Immunity 53

LifeProNow

APRIL 11, 2023

April 11, 2023: “AstraZeneca, Swedish Orphan Biovitrum AB (publ) (Sobi) and Sanofi have updated and simplified their contractual arrangements relating to the development and commercialisation of nirsevimab in the US. billion, to be recognised in Core Other operating income in 2023. AstraZeneca will record a gain of $0.7

Immunization 130

Immunization Immunity 130

ALiEM - Pharm Pearls

DECEMBER 18, 2023

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System. Copyright Images and cases from the Society of Academic Emergency Medicine (SAEM) Clinical Images Exhibit at the 2023 SAEM Annual Meeting | Copyrighted by SAEM 2023 – all rights reserved. Int J Mol Sci.

Immunization 177

Immunization Immunity 177

Express Pharma

OCTOBER 16, 2024

Ophelia Chan, Business Fundamentals Senior Analyst at GlobalData, comments, “The COVID-19 pandemic highlighted the key advantages of mRNA technology in vaccine development, including rapid production, precise immune targeting, and streamlined manufacturing- factors that drove the success of mRNA-based COVID-19 vaccines.” billion in 2030.

Vaccines 104

Vaccines Immunization Immunity Diabetes 104

Express Pharma

APRIL 17, 2023

Prometheus is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialisation of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases. The transaction is expected to close in the third quarter of 2023.

Immunity 98

Immunity Immunization Research Laboratories Labelling 98

Express Pharma

FEBRUARY 9, 2024

Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. The product will be manufactured at the group’s formulation manufacturing facility at Baddi, Himachal Pradesh.

Immunity 104

Immunity Immunization 104

Pharmafile

APRIL 18, 2023

CET/4:00 p.m. read more

Immunity 40

Immunity Immunization Vaccines 40

Express Pharma

MAY 8, 2024

billion, compared to the last 12-month (April 2023 to March 2024) average of 94 deals worth $20 billion. Vertex Pharmaceuticals Inc, a biotechnology company, to acquire Alpine Immune Sciences Inc, a clinical stage biotechnology company, for a consideration of approximately $4.9 billion in cash.

Immunization 105

Immunization Immunity 105

Pharmaceutical Technology

APRIL 17, 2023

Prometheus Biosciences uses precision medicine to discover, develop and commercialise new therapeutic and companion diagnostic products to treat immune-mediated diseases. The company intends to advance the mAb into Phase III trials for UC and CD in 2023. TL1A is implicated in intestinal inflammation and fibrosis.

Immunization 105

Immunization Immunity 105

European Pharmaceutical Review

NOVEMBER 25, 2022

Certain RNA methyltransferases regulate RNA sensing and innate immune activation and represent novel immune-regulatory targets. We anticipate presenting results from our Phase I study in 2023.” In addition, STC-15 has shown efficacy in leukaemia models via mechanisms including inhibition of leukaemia stem cell function.

Immunity 98

Immunity Immunization 98